CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. Moderate threat of substitutes
3.3.4. Moderate threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of high blood pressure cases
3.4.1.2. Technological advancements in digital sphygmomanometer
3.4.1.3. Government initiatives regarding hypertension and monitoring
3.4.2. Restraints
3.4.2.1. Less accuracy in results obtained by digital sphygmomanometer
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Arm Type
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Wrist Type
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: DIGITAL SPHYGMOMANOMETER MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals and clinics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Home care settings
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: DIGITAL SPHYGMOMANOMETER MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key trends and opportunities
6.2.2. Market size and forecast, by Type
6.2.3. Market size and forecast, by End User
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Key market trends, growth factors and opportunities
6.2.4.1.2. Market size and forecast, by Type
6.2.4.1.3. Market size and forecast, by End User
6.2.4.2. Canada
6.2.4.2.1. Key market trends, growth factors and opportunities
6.2.4.2.2. Market size and forecast, by Type
6.2.4.2.3. Market size and forecast, by End User
6.2.4.3. Mexico
6.2.4.3.1. Key market trends, growth factors and opportunities
6.2.4.3.2. Market size and forecast, by Type
6.2.4.3.3. Market size and forecast, by End User
6.3. Europe
6.3.1. Key trends and opportunities
6.3.2. Market size and forecast, by Type
6.3.3. Market size and forecast, by End User
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Key market trends, growth factors and opportunities
6.3.4.1.2. Market size and forecast, by Type
6.3.4.1.3. Market size and forecast, by End User
6.3.4.2. France
6.3.4.2.1. Key market trends, growth factors and opportunities
6.3.4.2.2. Market size and forecast, by Type
6.3.4.2.3. Market size and forecast, by End User
6.3.4.3. UK
6.3.4.3.1. Key market trends, growth factors and opportunities
6.3.4.3.2. Market size and forecast, by Type
6.3.4.3.3. Market size and forecast, by End User
6.3.4.4. Italy
6.3.4.4.1. Key market trends, growth factors and opportunities
6.3.4.4.2. Market size and forecast, by Type
6.3.4.4.3. Market size and forecast, by End User
6.3.4.5. Spain
6.3.4.5.1. Key market trends, growth factors and opportunities
6.3.4.5.2. Market size and forecast, by Type
6.3.4.5.3. Market size and forecast, by End User
6.3.4.6. Rest of Europe
6.3.4.6.1. Key market trends, growth factors and opportunities
6.3.4.6.2. Market size and forecast, by Type
6.3.4.6.3. Market size and forecast, by End User
6.4. Asia-Pacific
6.4.1. Key trends and opportunities
6.4.2. Market size and forecast, by Type
6.4.3. Market size and forecast, by End User
6.4.4. Market size and forecast, by country
6.4.4.1. Japan
6.4.4.1.1. Key market trends, growth factors and opportunities
6.4.4.1.2. Market size and forecast, by Type
6.4.4.1.3. Market size and forecast, by End User
6.4.4.2. China
6.4.4.2.1. Key market trends, growth factors and opportunities
6.4.4.2.2. Market size and forecast, by Type
6.4.4.2.3. Market size and forecast, by End User
6.4.4.3. India
6.4.4.3.1. Key market trends, growth factors and opportunities
6.4.4.3.2. Market size and forecast, by Type
6.4.4.3.3. Market size and forecast, by End User
6.4.4.4. Australia
6.4.4.4.1. Key market trends, growth factors and opportunities
6.4.4.4.2. Market size and forecast, by Type
6.4.4.4.3. Market size and forecast, by End User
6.4.4.5. South Korea
6.4.4.5.1. Key market trends, growth factors and opportunities
6.4.4.5.2. Market size and forecast, by Type
6.4.4.5.3. Market size and forecast, by End User
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Key market trends, growth factors and opportunities
6.4.4.6.2. Market size and forecast, by Type
6.4.4.6.3. Market size and forecast, by End User
6.5. LAMEA
6.5.1. Key trends and opportunities
6.5.2. Market size and forecast, by Type
6.5.3. Market size and forecast, by End User
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Key market trends, growth factors and opportunities
6.5.4.1.2. Market size and forecast, by Type
6.5.4.1.3. Market size and forecast, by End User
6.5.4.2. Saudi Arabia
6.5.4.2.1. Key market trends, growth factors and opportunities
6.5.4.2.2. Market size and forecast, by Type
6.5.4.2.3. Market size and forecast, by End User
6.5.4.3. South Africa
6.5.4.3.1. Key market trends, growth factors and opportunities
6.5.4.3.2. Market size and forecast, by Type
6.5.4.3.3. Market size and forecast, by End User
6.5.4.4. Rest of LAMEA
6.5.4.4.1. Key market trends, growth factors and opportunities
6.5.4.4.2. Market size and forecast, by Type
6.5.4.4.3. Market size and forecast, by End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2021
CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company overview
8.1.2. Key Executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Contec Medical Systems Co.,Ltd
8.2.1. Company overview
8.2.2. Key Executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.3. Microlife Corporation
8.3.1. Company overview
8.3.2. Key Executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.4. Panasonic Holdings Corporation
8.4.1. Company overview
8.4.2. Key Executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Halma plc
8.5.1. Company overview
8.5.2. Key Executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.5.6. Business performance
8.6. OMRON Corporation
8.6.1. Company overview
8.6.2. Key Executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.6.6. Business performance
8.6.7. Key strategic moves and developments
8.7. A&D HOLON Holdings Company, Limited
8.7.1. Company overview
8.7.2. Key Executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.7.6. Business performance
8.8. Rossmax International Ltd
8.8.1. Company overview
8.8.2. Key Executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. American Diagnostic Corporation
8.9.1. Company overview
8.9.2. Key Executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.9.6. Key strategic moves and developments
8.10. Yu Yue Medical
8.10.1. Company overview
8.10.2. Key Executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
TABLE 01. GLOBAL DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 02. DIGITAL SPHYGMOMANOMETER MARKET FOR ARM TYPE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 03. DIGITAL SPHYGMOMANOMETER MARKET FOR WRIST TYPE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 04. GLOBAL DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 05. DIGITAL SPHYGMOMANOMETER MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 06. DIGITAL SPHYGMOMANOMETER MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 07. DIGITAL SPHYGMOMANOMETER MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. DIGITAL SPHYGMOMANOMETER MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 9. NORTH AMERICA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 10. NORTH AMERICA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 11. NORTH AMERICA DIGITAL SPHYGMOMANOMETER MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 12. U.S. DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 13. U.S. DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 14. CANADA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 15. CANADA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 16. MEXICO DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 17. MEXICO DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 18. EUROPE DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 19. EUROPE DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 20. EUROPE DIGITAL SPHYGMOMANOMETER MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 21. GERMANY DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 22. GERMANY DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 23. FRANCE DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. FRANCE DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 25. UK DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 26. UK DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 27. ITALY DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 28. ITALY DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 29. SPAIN DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. SPAIN DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. REST OF EUROPE DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. REST OF EUROPE DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 33. ASIA-PACIFIC DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. ASIA-PACIFIC DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 35. ASIA-PACIFIC DIGITAL SPHYGMOMANOMETER MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 36. JAPAN DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. JAPAN DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 38. CHINA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 39. CHINA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 40. INDIA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 41. INDIA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 42. AUSTRALIA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. AUSTRALIA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 44. SOUTH KOREA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. SOUTH KOREA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 46. REST OF ASIA-PACIFIC DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 47. REST OF ASIA-PACIFIC DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 48. LAMEA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. LAMEA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 50. LAMEA DIGITAL SPHYGMOMANOMETER MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 51. BRAZIL DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. BRAZIL DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 53. SAUDI ARABIA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. SAUDI ARABIA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 55. SOUTH AFRICA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. SOUTH AFRICA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 57. REST OF LAMEA DIGITAL SPHYGMOMANOMETER MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. REST OF LAMEA DIGITAL SPHYGMOMANOMETER MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. BAXTER INTERNATIONAL INC.: KEY EXECUTIVES
TABLE 60. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 61. BAXTER INTERNATIONAL INC.: PRODUCT SEGMENTS
TABLE 62. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 63. BAXTER INTERNATIONAL INC.: KEY STRATERGIES
TABLE 64. CONTEC MEDICAL SYSTEMS CO.,LTD: KEY EXECUTIVES
TABLE 65. CONTEC MEDICAL SYSTEMS CO.,LTD: COMPANY SNAPSHOT
TABLE 66. CONTEC MEDICAL SYSTEMS CO.,LTD: PRODUCT SEGMENTS
TABLE 67. CONTEC MEDICAL SYSTEMS CO.,LTD: PRODUCT PORTFOLIO
TABLE 68. MICROLIFE CORPORATION: KEY EXECUTIVES
TABLE 69. MICROLIFE CORPORATION: COMPANY SNAPSHOT
TABLE 70. MICROLIFE CORPORATION: PRODUCT SEGMENTS
TABLE 71. MICROLIFE CORPORATION: PRODUCT PORTFOLIO
TABLE 72. PANASONIC HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 73. PANASONIC HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 74. PANASONIC HOLDINGS CORPORATION: PRODUCT SEGMENTS
TABLE 75. PANASONIC HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 76. HALMA PLC: KEY EXECUTIVES
TABLE 77. HALMA PLC: COMPANY SNAPSHOT
TABLE 78. HALMA PLC: PRODUCT SEGMENTS
TABLE 79. HALMA PLC: PRODUCT PORTFOLIO
TABLE 80. OMRON CORPORATION: KEY EXECUTIVES
TABLE 81. OMRON CORPORATION: COMPANY SNAPSHOT
TABLE 82. OMRON CORPORATION: SERVICE SEGMENTS
TABLE 83. OMRON CORPORATION: PRODUCT PORTFOLIO
TABLE 84. OMRON CORPORATION: KEY STRATERGIES
TABLE 85. A&D HOLON HOLDINGS COMPANY, LIMITED: KEY EXECUTIVES
TABLE 86. A&D HOLON HOLDINGS COMPANY, LIMITED: COMPANY SNAPSHOT
TABLE 87. A&D HOLON HOLDINGS COMPANY, LIMITED: PRODUCT SEGMENTS
TABLE 88. A&D HOLON HOLDINGS COMPANY, LIMITED: PRODUCT PORTFOLIO
TABLE 89. ROSSMAX INTERNATIONAL LTD: KEY EXECUTIVES
TABLE 90. ROSSMAX INTERNATIONAL LTD: COMPANY SNAPSHOT
TABLE 91. ROSSMAX INTERNATIONAL LTD: PRODUCT SEGMENTS
TABLE 92. ROSSMAX INTERNATIONAL LTD: PRODUCT PORTFOLIO
TABLE 93. AMERICAN DIAGNOSTIC CORPORATION: KEY EXECUTIVES
TABLE 94. AMERICAN DIAGNOSTIC CORPORATION: COMPANY SNAPSHOT
TABLE 95. AMERICAN DIAGNOSTIC CORPORATION: PRODUCT SEGMENTS
TABLE 96. AMERICAN DIAGNOSTIC CORPORATION: PRODUCT PORTFOLIO
TABLE 97. AMERICAN DIAGNOSTIC CORPORATION: KEY STRATERGIES
TABLE 98. YU YUE MEDICAL: KEY EXECUTIVES
TABLE 99. YU YUE MEDICAL: COMPANY SNAPSHOT
TABLE 100. YU YUE MEDICAL: PRODUCT SEGMENTS
TABLE 101. YU YUE MEDICAL: PRODUCT PORTFOLIO
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/